Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian‐cancer cell lines
- 29 May 1995
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 61 (5) , 643-648
- https://doi.org/10.1002/ijc.2910610510
Abstract
Human ovarian carcinoma cells (2008 and its cisplatin‐resistant sub‐line 2008/C13*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFNγ). IFNγ produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/C13* cells to IFNγ resulted in a time‐dependent decrease of cellular glutathione and total glutathione‐S‐transferase activity, principally the π isoform. By contrast, the treatment of 2008 and 2008/C13* cell lines with IFNγ induced rather than suppressed metallothionein IIA mRNA levels. IFNγ changed neither the formation of total platinum‐DNA adducts, nor DNA repair. A significant decrease in c‐erbB‐2 expression was observed both in sensitive and in resistant cell lines after treatment with IFNγ, and this decrease was dose‐dependent. Our results indicate that the mechanism of IFNγ‐induced sensitization in human ovarian‐cancer cell lines is multifactorial. © 1995 Wiley‐Liss, Inc.Keywords
This publication has 18 references indexed in Scilit:
- Modulation of cisplatin cytotoxicity by human recombinant interferon-γ in human ovarian cancer cell linesEuropean Journal Of Cancer, 1994
- New platinum antitumor complexesPublished by Elsevier ,1993
- Inhibition of DNA Repair and Sensitization of Cisplatin in Human Ovarian Carcinoma Cells by Interleukin-1αBiochemical and Biophysical Research Communications, 1993
- Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cellsInternational Journal of Cancer, 1991
- Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell linesCancer Letters, 1989
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionChemico-Biological Interactions, 1988
- Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1987
- Serial determinations of glutathione levels and glutathione-related enzyme activities in human tumor cels in vitroBiochemical Pharmacology, 1986
- Human metallothionein genes—primary structure of the metallothionein-II gene and a related processed geneNature, 1982